exact
IG-DART
exact
IG-DART
Trademarks matching 'ig-dart'
Summary of page content
2013-09-19
US
-
35
Advertising; business management; business administration; office functions
production and product commercialization for third parties of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases
-
42
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software
discovery, research, development, engineering and testing of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; providing medical and scientific research information relating to pharmaceutical substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases
602
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
2019-05-10
2020-05-31
IG-DART MacroGenics, Inc.
2011-09-21
US
-
5
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
pharmaceutical preparations and substances, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases
606
ABANDONED - NO STATEMENT OF USE FILED
2014-11-24
2020-05-31
IG-DART MacroGenics, Inc.